• What T2D Therapy Have You Considered for Your Patients After Metformin?

  • Aug 22 2022
  • Length: 40 mins
  • Podcast

What T2D Therapy Have You Considered for Your Patients After Metformin?

Listen for free

View show details

  • Summary

  • How common is treatment inertia in the treatment of adult patients with T2D and what can be done about it? Join a multidisciplinary panel including Jim Gavin, MD, PhD; Steve Vacalis, DO; and Jodi Strong, DNP, CDE, BC-ADM, CPT as they discuss and share their insights on the issues surrounding therapeutic inertia. They will also evaluate when to use a GLP-1 RA, and a clinical trial comparing the efficacy and safety of a GLP-1 RA versus a DPP-4i.

    This program is intended for clinicians. The information presented is aligned with the views and opinions of the speakers and is sponsored by Novo Nordisk. This podcast is not to be used as medical advice and is intended for educational purposes only.

    Faculty Presenters:

    James R. Gavin III, MD, PhD
    Clinical Professor of Medicine, Emory University
    Chief Medical Officer, Healing Our Village, Inc.
    Atlanta, Georgia

    Jodi Strong, DNP, CDCES, BC-ADM, CPT
    Aspirus Medical Group
    Stevens Point, Wisconsin

    Steve Vacalis, DO
    Senior Lead Physician
    CaroMont Family Medicine, CaroMont Regional Medical Center 
    Gastonia, North Carolina
    Show More Show Less
Show More Show Less
activate_samplebutton_t1

What listeners say about What T2D Therapy Have You Considered for Your Patients After Metformin?

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com.au reviews

Amazon Reviews
No Reviews are Available
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.